Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 384-392

  Pierce, R Christopher ^a   Born, Brenna ^a   Adams, Meredith ^a   Kalivas, Peter W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; HYPERACTIVITY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TEGMENTUM MESENCEPHALI;

EID: 0030426655     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. ACKERMAN, J. M. AND WHITE, F. J.: A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117: 181-187, 1990.
2. AKAOKA, H., CHARLETY, P., SAUNIER, C.-F., BUDA, M. AND CHOUVET, G.: Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors. Neuroscience 49: 879-891, 1992.
3. AKIMOTO, K., HAMAMURA, T., KAZAHAYA, Y., AKIYAMA, K. AND OTSUKI, S.: Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine: An in vivo dialysis study in freely moving rats. Brain Res. 507: 344-346, 1990.
4. ALTAR, C. A. AND HAUSER, K.: Topography of substantia nigra innervation by D1 receptor-containing striatal neurons. Brain Res. 410: 1-11, 1987.
5. ANTELMAN, S. M. AND CHIODO, L. A.: Dopamine autoreceptor subsensitivity: A mechanism common to the treatment of depression and the induction of amphetamine psychosis. Biol. Psychiatry 16: 717-727, 1981.
6. ARNT, J. AND PERREGAARD, J.: Synergistic interaction between dopamine D-1 and D-2 receptor agonists: Circling behavior of rats with hemitransection. Eur. J. Pharmacol. 143: 45-53, 1987.
7. ASIN, K. E. AND MONTANA, W. E.: Rotation following intranigral injection of a selective D-1 or a selective D-2 dopamine receptor agonist in rats. Pharmacol. Biochem. Behav. 29: 89-92, 1988.
8. BECKSTEAD, R. M.: Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: The uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Neuroscience 27: 851-863, 1988.
9. BEITNER-JOHNSON, D., GUITART, X. AND NESTLEB, E. J.: Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12: 2165-2176, 1992.
10. BOLDRY, R. C., WILLINS, D. L., WALLACE, L. J. AND URETSKY, N. J.: The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Brain Res. 559: 100-108, 1991.
11. BREESE, G. R., DUNCAN, G. E., NAPIER, C., BONDY, S. C., IORIO, L. C. AND MUELLER, R. A.: 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240:167-176, 1987.
12. CADOR, M., BJIJOU, Y. AND STINUS, L.: Evidence of a complete independence of the neurobiological substrates for the induction and expression of behaivoral sensitization to amphetamine. Neuroscience 65: 385-395, 1995.
13. CAMERON, D. L. AND WILLIAMS, J. T.: Dopamine D1 receptors facilitate transmitter release. Nature (Lond.) 366: 344-347, 1993.
14. COLLE, L. M. AND WISE, R. A.: Circling induced by intra-accumbens amphetamine injections. Psychopharmacology 105: 157-161, 1991.
15. DELFS, J. M. AND KELLEY, A. E.: The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 39: 59-67, 1990.
16. DELFS, J. M., SCHREIBER, L. AND KELLEY, A. E.: Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J. Neurosci. 10: 303-310, 1990.
17. DOUGHERTY, G. G., JR. AND ELLINWOOD, E. H., JR.: Chronic d-amphetamine in nucleus accumbens: Lack of tolerance or reverse tolerance of locomotor activity. Life Sci. 28: 2295-2298, 1981.
18. DREHER, J. K. AND JACKSON, D. M.: Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res. 487: 267-277, 1989.
19. HENRY, D. J., GREENE, M. A. AND WHITE, F. J.: Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration. J. Pharmacol. Exp. Ther. 251: 833-839, 1989.
20. HENRY, D. J. AND WHITE, F. J.: Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258: 882-890, 1991.
21. HIGASHI, H., INANAGA, K., NISHI, S. AND UCHIMURA, N.: Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pretreatment. J. Physiol. (Lond.) 408: 587-603, 1989.
22. HOOKS, M. S., JONES, G. H., LIEM, B. J. AND JUSTICE, J. B., JR.: Sensitization and individual differences to IP amphetamine, cocaine or caffeine following repeated intracranial amphetamine infusions. Pharmacol. Biochem. Behav. 43: 815-823, 1992.
23. JOHNSON, S. W., SEUTIN, V. AND NORTH, R. A.: Burst firing in dopamine neurons induced by N-methyl-D-aspartate: Role of electrogenic sodium pump. Science (Wash. DC) 258: 665-667, 1992.
24. KALIVAS, P. W.: Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18: 75-113, 1993.
25. KALIVAS, P. W.: Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Alcohol Drug Dep. 37:95-100, 1995.
26. KALIVAS, P. W. AND ALESDATTER, J. E.: Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267: 486-495, 1993.
27. KALIVAS, P. W. AND DUFFY, P.: The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58, 1990.
28. KALIVAS, P. W. AND DUFFY, P.: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13: 266-275, 1993a.
29. KALIVAS, P. W. AND DUFFY, P.: Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J. Neurosci. 13: 276-284, 1993b.
30. KALIVAS, P. W. AND DUFFY, T.: D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 15: 5379-5388, 1995.
31. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244, 1991.
32. KALIVAS, P. W. AND WEBER, B.: Amphetamine injection into the A10 dopamine region sensitizes rate to peripheral amphetamine, and cocaine. J. Pharmacol. Exp. Ther. 245: 1095-1102, 1988.
33. KAMATA, K. AND REBEC, G. V.: Dopaminergic and neostriatal neurons: Dose-dependent changes in sensitivity to amphetamine following long-term treatment. Neuropharmacology 22: 1377-1382, 1983.
34. KAMATA, K. AND REBEC, G. V.: Nigra dopaminergic neurons: Differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine. Brain Res. 32: 147-150, 1984.
35. KARLER, R., CALDER, L. D., CHAUDHRY, I. A. AND TURKANIS, S. A.: Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45: 599-606, 1989.
36. KARLER, R., CHAUDHRY, I. A., CALDER, L. D. AND TURKANIS, S. A.: Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537: 76-82, 1990.
37. KARLER, R., FINNEGAN, K. T. AND CALDER, L. D.: Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res. 603: 9-24, 1993.
38. MANSOUR, A., MEADOR-WOODRUFF, J. H., ZHOU, Q., CIVELLI, O., AKIL, H. AND WATSON, S. J., JR.: A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46: 959-971, 1992.
39. MATTINGLY, B. A., HART, T. C., LIM, K. AND PERKINS, C.: Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology 114: 239-242, 1994.
40. MAYFIELD, R. D., LARSON, G. AND ZAHNISER, N. R.: Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573: 331-335, 1992.
41. MEREU, G., COSTA, E., ARMSTRONG, D. M. AND VICINI, S.: Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neurosci. 11: 1359-1366, 1991.
42. MEYER, M. E., VAN HARTESVELDT, C. AND POTTER, T. J.: Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats. Synapse 13: 310-314, 1993.
43. NEISEWANDER, J. L., O'DELL, L. AND REDMOND, J. C.: Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion. Brain Res. 671: 201-212, 1995.
44. NESTLER, E. J., TERWILLIGER, R. Z., WALKER, J. R., SEVARINO, K. A. AND DUMAN, R. S.: Chronic cocaine treatment decreases levels of the G protein subunits Giα and Goα in discrete regions of rat brain. J. Neurochem. 55: 1079-1082, 1990.
45. PARSONS, L. H. AND JUSTICE, J. B., JR.: Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61: 1611-1619, 1993.
46. PATRICK, S. L., THOMPSON, T. L., WALKER, J. M. AND PATRICK, R. L.: Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538: 343-346, 1991.
47. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
48. PERUGINI, M. AND VEZINA, P.: Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270: 690-696, 1994.
49. PETTIT, H. O., PAN, H.-T., PARSONS, L. H. AND JUSTICE, J. B., JR.: Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J. Neurochem. 55: 798-804, 1990.
50. PHILLIPS, G. D., HOWES, S. R., WHITELAW, R. B., ROBBINS, T. W. AND EVERITT, B. J.: Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioral satiety sequence. Psychopharmacology 117: 82-90, 1995.
51. PIERCE, R. C. AND KALIVAS, P. W.: Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275: 1019-1029, 1995.
52. ROBINSON, T. E., JURSON, P. A., BENNETT, J. A. AND BENTGEN, K. M.: Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res. 462: 211-222, 1988.
53. ROBINSON, T. E. AND WISHAW, I. Q.: Normalization of extracellular dopamine in the striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats. Brain Res. 450: 209-224, 1988.
54. ROWLETT, J. K., MATTINGLY, B. A. AND BARDO, M. T.: Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: Assessment of the role of D1 receptor stimlation. Synapse 14: 160-168, 1993.
55. SANTIAGO, M. AND WESTERINK, B. H. C.: The regulation of dopamine release from nigrostriatal neurons in conscious rats: The role of somatodendritic autoreceptors. Eur. J. Pharmacol. 204: 79-85, 1991.
56. SCHENK, S., VALADEZ, A., MCNAMARA, C., HOUSE, D. T., HIGLEY, D., BANKSON, M. G., GIBBS, S. AND HORGER, B. A.: Development and expression of sensitization to cocaine's reinforcing properties: Role of NMDA receptors. Psychopharmacology 111: 332-338, 1993.
57. SEGAL, D. S. AND KUCZENSKI, R.: In vivo microdialysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sen7 sitization produced by repeated amphetamine pretreatment. Brain Res. 521: 330-332, 1992a.
58. SEGAL, D. S. AND KUCZENSKI, R.: Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577: 351-355, 1992b.
59. SHIMOSATO, K. AND SAITO, T.: Suppressive effect of cyclohexamide on behavioral sensitization to methamphetamine in mice. Eur. J. Pharmacol. 234: 67-75, 1993.
60. SORG, B. A., CHEN, S.-Y. AND KALIVAS, P. W.: Time course of tyrosine hydroxylase expression following behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 266: 424-430, 1993.
61. SORG, B. A. AND ULIBARRI, C.: Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse 20: 217-224, 1995.
62. STARR, M. S. AND STARR, B. S.: Circling evoked by intranigral SKF 38393: A GABA-mediated D-1 response? Pharmacol. Biochem. Behav. 32: 849-851, 1989.
63. STATON, D. M. AND SOLOMON, P. R.: Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat. Physiol. Psychol. 12: 159-162, 1984.
64. STEKETEE, J. D. AND KALIVAS, P. W.: Microinjection of the D2 agonist, quinpirole, into the A10 dopamine region blocks amphetamine, but not cocainestimulated motor activity. J. Pharmacol. Exp. Ther. 261: 811-818, 1992.
65. STEWART, J. AND DRUHAN, J. P.: The development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetative NMDA receptor antagonist, MK-801. Psychopharmacology 110: 125-132, 1993.
66. STEWART, J. AND VEZINA, P.: Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495: 401-406, 1989.
67. STRIPLIN, C. AND KALIVAS, P. W.: Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse 14: 10-15, 1993.
68. TERWILLIGER, R., BEITNER-JOHNSON, D., SVARINO, K. A., CRAIN, S. M. AND NESTLER, E. J.: A general role for adaptations in G-proteins and cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548: 100-110, 1991.
69. TIMMERMAN, W., ZWAVELING, J. AND WESTERINK, B. H. C.: Dopaminergic modulation of the GABA release in the substantia nigra reticulata. In Monitoring Molecules in Neuroscience, edited by H. Rollema, B. H. C. Westerink and W. J. Drijfhout, pp. 105-107, Krips Repro, Meppel, The Netherlands, 1991.
70. VEZINA, P.: Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat. Brain Res. 605: 332-337, 1993.
71. VEZINA, P. AND STEWART, J.: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499: 108-120, 1989.
72. VEZINA, P. AND STEWART, J.: Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res. 516: 99-106, 1990.
73. WADDINGTON, J. L.: Functional interactions between D-1 and D-2 dopamine receptor systems: Their role in the regulation of psychomotor behavior, putative mechanisms, and clinical relevance. J. Psychopharmacol. 3:54-63, 1989.
74. WOLF, M. E. AND KHANSA, M. R.: Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562: 164-168, 1991.
75. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODERSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.